Parabilis Medicines, Inc. (PBLS)

NASDAQ: PBLS · Real-Time Price · USD

31.96

+0.14 (0.44%)

At close: Jul 28, 2026, 4:00 PM EDT

31.96

0.00 (0.00%)

Pre-market: Jul 29, 2026, 4:58 AM EDT

Parabilis Medicines Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024
Net Income	-145.89	-117.91
Depreciation & Amortization	2.5	2.11
Stock-Based Compensation	3.32	4.31
Other Adjustments	7.24	6.97
Changes in Accounts Payable	13.59	9.28
Changes in Other Operating Activities	-4.47	-8.37
Operating Cash Flow	-123.71	-103.61
Operating Cash Flow Growth	-	-
Capital Expenditures	-0.31	-0.88
Purchases of Investments	-16.66	-90.86
Proceeds from Sale of Investments	56.73	121.98
Investing Cash Flow	39.76	30.24
Long-Term Debt Repaid	-3.08	-
Net Long-Term Debt Issued (Repaid)	-3.08	-
Issuance of Common Stock	0.03	1.07
Net Common Stock Issued (Repurchased)	0.03	1.07
Issuance of Preferred Stock	67.49	77.51
Net Preferred Stock Issued (Repurchased)	67.49	77.51
Other Financing Activities	-0.06	-0.51
Financing Cash Flow	64.38	78.07
Net Cash Flow	-19.57	4.7
Free Cash Flow	-124.02	-104.49
Free Cash Flow Growth	-	-
Free Cash Flow Per Share	-61.30	-54.02
Levered Free Cash Flow	-178.7	-159.34
Unlevered Free Cash Flow	-140.77	-123.99

SEC Filings: 10-K · 10-Q